You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
AXA安盛與中生科服簽署諒解備忘錄 共同探索創新癌症醫療技術
阿思達克 07-15 17:17
AXA安盛宣布與中國生物科技服務(08037.HK)簽署策略性合作諒解備忘錄,共同探索創新癌症醫療技術,包括硼中子捕獲治療(BNCT)及相關服務,為客戶提供多元化的治療選擇。 AXA安盛香港及澳門首席人壽及醫療保險業務總監李佩瑜表示,公司一直緊密關注醫療市場的趨勢,積極探索創新醫療方案,並將其融入醫療保障計劃中,以確保服務與時並進,未來將持續強化保險產品,期望能為有需要的客戶提供創新醫療選擇。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account